Breaking News: The FDA has granted approval of Kisunla (donanemab) for the treatment of people living with early symptomatic Alzheimer’s disease. We celebrate Kisunla’s approval, as more treatment options mean a greater opportunity for #MoreTime.
https://t.co/vBTSicKyZ4
Do all #Leos feel like they are a lazy perfectionist with ADHD and chronic fatigue who is pretty chill besides the occasional panic attack and loves their friends but hates people?